University of California San Francisco Give to UCSF
https://ucsf.zoom.us/j/92507991004?pwd=UGg0NU0xS2R0Q1RtREpSK2UzUyt2dz09

The Omicron Variant and the New Antivirals: How Much Will These Change the Pandemic in 2022?

Session moderated by Bob Wachter

In this UCSF Medicine Covid Grand Rounds, we’ll speak to two Covid experts – our own Dr. Annie Luetkemeyer and Prof. John Moore of the Weill Cornell Medical College. Dr. Luetkemeyer will help us navigate the emerging world of the new oral antivirals for Covid-19 – how they work, what are good use cases, when to use monoclonal antibodies versus the new antivirals, the potential role of fluvoxamine, and how we might integrate these therapies into our Covid-19 arsenal. Next, Prof. John Moore, an internationally known expert on microbiology and immunology, will help us distinguish hype from fact regarding the new Omicron variant in terms of its impact on transmission, immune escape, and severity – and what its emergence is likely to mean for the future course of the pandemic.

Speakers:
Annie Luetkemeyer, MD, is a UCSF Professor of Medicine in the Division of HIV, ID and Global Medicine at ZSFG.

John Moore, PhD, is a Professor of Microbiology and Immunology at the Weill Cornell Medical College.

Zoom Information:
Join from a PC, Mac, iPad, iPhone or Android device by clicking:
https://ucsf.zoom.us/j/92507991004?pwd=UGg0NU0xS2R0Q1RtREpSK2UzUyt2dz09
Webinar ID: 925 0799 1004
Passcode: 500062

Event Details

  • Julianne Bautista
  • Chris Overton

2 people are interested in this event


Zoom Information:
Join from a PC, Mac, iPad, iPhone or Android device by clicking:
https://ucsf.zoom.us/j/92507991004?pwd=UGg0NU0xS2R0Q1RtREpSK2UzUyt2dz09
Webinar ID: 925 0799 1004
Passcode: 500062

Or join by phone by dialing (for higher quality, dial a number based on your current location):
US: +1 669 900 6833  or +1 346 248 7799  or +1 312 626 6799  or
+1 646 558 8656  or +1 253 215 8782  or +1 301 715 8592
International numbers available: https://ucsf.zoom.us/u/abBh6VatYU

User Activity

No recent activity